Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Did You Know Previous | All Articles This Week | Next
This article originally posted 06 September, 2009 and appeared in  Issue 485

Doctors Bust Myths about Insulin

Doctors Bust Myths about Insulin. People newly diagnosed with Type 2 diabetes often resist taking insulin because they fear gaining weight, developing low blood sugar, and seeing their quality of life decline. A new study suggests that those fears are largely unfounded. The UT Southwestern team studied the effectiveness of insulin-based therapy as an initial treatment option to newly diagnosed Type 2 diabetics. They compared rates of compliance, satisfaction, effectiveness, safety and quality of life among 58 patients, who were randomly allocated to standard triple drug therapy or insulin plus metformin. After 3 years, the researchers report, patients taking insulin plus metformin had fewer low blood sugar or "hypoglycemic" events, gained less weight and reported high satisfaction levels with the insulin. In fact, all of the patients in the insulin group said that they would be willing to continue this form of treatment after the study.

Diabetes Care Aug.2009.

 

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 06 September, 2009 and appeared in  Issue 485

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control